[Effect of rubomycin C on lysosomes in vivo and in vitro].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D002403:Cathepsins / Q000032:analysis; D002463:Cell Membrane Permeability / Q000187:drug effects*; D003609:Dactinomycin / Q000494:pharmacology*; D003851:Deoxyribonucleases / Q000032:analysis; D003864:Depression, Chemical; D005696:Galactosidases / Q000037:antagonists & inhibitors; D005959:Glucosidases / Q000037:antagonists & inhibitors; D005966:Glucuronidase / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008247:Lysosomes / Q000187:drug effects*; D008297:Male; D008937:Mitomycins / Q000494:pharmacology*; D051381:Rats; D012260:Ribonucleases / Q000032:analysis; D013268:Stimulation, Chemical; D013429:Sulfatases / Q000037:antagonists & inhibitors; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D003609:Dactinomycin; D003851:Deoxyribonucleases; D012260:Ribonucleases; D013429:Sulfatases; D005696:Galactosidases; D005959:Glucosidases; D005966:Glucuronidase; D002403:Cathepsins
Deĭstvie rubomitsina C na lizosomy in vivo i in vitro.